scispace - formally typeset
S

Shelagh B. Coutts

Researcher at University of Calgary

Publications -  217
Citations -  13347

Shelagh B. Coutts is an academic researcher from University of Calgary. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 52, co-authored 188 publications receiving 10997 citations. Previous affiliations of Shelagh B. Coutts include Allen Institute for Brain Science & Foothills Medical Centre.

Papers
More filters
Journal ArticleDOI

Embolic strokes of undetermined source: the case for a new clinical construct

TL;DR: In this article, the authors proposed that embolic strokes of undetermined source are a therapeutically relevant entity, which are defined as a non-lacunar brain infarct without proximal arterial stenosis or cardioembolic sources, with a clear indication for anticoagulation.
Journal ArticleDOI

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Kaberi Dasgupta, +68 more
TL;DR: The Canadian Hypertension Education Program reviews the hypertension literature annually and provides detailed recommendations regarding hypertension diagnosis, assessment, prevention, and treatment, and 4 new recommendations were added and 2 existing recommendations were modified this year.
Journal ArticleDOI

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension

Alexander A. Leung, +77 more
TL;DR: In the diagnosis and assessment of hypertension, automated office blood pressure, taken without patient-health provider interaction, is now recommended as the preferred method of measuring in-office blood pressure as mentioned in this paper.
Journal ArticleDOI

Growth factor modulation of p53-mediated growth arrest versus apoptosis.

TL;DR: Observations suggest additional molecular mechanisms that can contribute to the development of radioresistance and resistance to apoptosis during tumorigenesis and provide an explanation for the observed lack of p53 mutations in some tumor types.